Zepp Health Corporation (ZEPP)
NYSE: ZEPP · Real-Time Price · USD
2.630
0.00 (0.00%)
Nov 20, 2024, 3:59 PM EST - Market closed
Zepp Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Revenue | 208.95 | 2,495 | 4,143 | 6,250 | 6,433 | 5,812 | Upgrade
|
| Revenue Growth (YoY) | -49.86% | -39.77% | -33.72% | -2.85% | 10.69% | 59.44% | Upgrade
|
| Cost of Revenue | 130.39 | 1,838 | 3,340 | 4,944 | 5,101 | 4,345 | Upgrade
|
| Gross Profit | 78.56 | 657.78 | 803.12 | 1,306 | 1,333 | 1,468 | Upgrade
|
| Selling, General & Admin | 69.02 | 503.07 | 696.24 | 696.62 | 620.46 | 430.44 | Upgrade
|
| Research & Development | 46.3 | 361.81 | 517.12 | 515.08 | 538.01 | 430.82 | Upgrade
|
| Operating Expenses | 115.32 | 864.88 | 1,213 | 1,212 | 1,158 | 861.26 | Upgrade
|
| Operating Income | -36.76 | -207.1 | -410.24 | 93.94 | 174.2 | 606.48 | Upgrade
|
| Interest Expense | -5.59 | -47.7 | -57 | -44.88 | -22.62 | - | Upgrade
|
| Interest & Investment Income | 3.61 | 21.92 | 12.33 | 16.69 | 46.12 | 33.48 | Upgrade
|
| Earnings From Equity Investments | 1.17 | 8.38 | 17.66 | 41.03 | -4.75 | -1.11 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.23 | -3.66 | 43.82 | 27.42 | -0.93 | 13.19 | Upgrade
|
| EBT Excluding Unusual Items | -37.34 | -228.17 | -393.43 | 134.19 | 192.01 | 652.04 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1.02 | -0.24 | 38.56 | 13.51 | 12.33 | -0.78 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 56.52 | - | Upgrade
|
| Pretax Income | -36.32 | -228.4 | -354.88 | 147.7 | 260.86 | 651.26 | Upgrade
|
| Income Tax Expense | 3.07 | -15.82 | -65.88 | 10.75 | 31.15 | 77.89 | Upgrade
|
| Earnings From Continuing Operations | -39.39 | -212.58 | -289 | 136.95 | 229.71 | 573.37 | Upgrade
|
| Minority Interest in Earnings | 0.04 | 0.47 | 0.69 | 0.85 | -0.95 | 1.83 | Upgrade
|
| Net Income | -39.36 | -212.12 | -288.31 | 137.8 | 228.75 | 575.2 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 2.45 | Upgrade
|
| Net Income to Common | -39.36 | -212.12 | -288.31 | 137.8 | 228.75 | 572.75 | Upgrade
|
| Net Income Growth | - | - | - | -39.76% | -60.23% | 69.15% | Upgrade
|
| Shares Outstanding (Basic) | 16 | 15 | 15 | 16 | 16 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 16 | 15 | 15 | 17 | 16 | 16 | Upgrade
|
| Shares Change (YoY) | 4.50% | -1.28% | -6.84% | 1.54% | 1.72% | 13.74% | Upgrade
|
| EPS (Basic) | -2.47 | -13.96 | -18.73 | 8.74 | 14.73 | 37.61 | Upgrade
|
| EPS (Diluted) | -2.50 | -13.96 | -18.73 | 8.32 | 14.08 | 35.84 | Upgrade
|
| EPS Growth | - | - | - | -40.91% | -60.71% | 341.64% | Upgrade
|
| Free Cash Flow | - | 287.37 | -795.78 | -278.49 | 73.75 | 393.72 | Upgrade
|
| Free Cash Flow Per Share | - | 18.91 | -51.70 | -16.85 | 4.53 | 24.61 | Upgrade
|
| Gross Margin | 37.60% | 26.36% | 19.39% | 20.89% | 20.71% | 25.25% | Upgrade
|
| Operating Margin | -17.59% | -8.30% | -9.90% | 1.50% | 2.71% | 10.43% | Upgrade
|
| Profit Margin | -18.84% | -8.50% | -6.96% | 2.20% | 3.56% | 9.85% | Upgrade
|
| Free Cash Flow Margin | - | 11.52% | -19.21% | -4.46% | 1.15% | 6.77% | Upgrade
|
| EBITDA | -29.2 | -152.65 | -351.62 | 145.83 | 201.33 | 623.7 | Upgrade
|
| EBITDA Margin | -13.98% | -6.12% | -8.49% | 2.33% | 3.13% | 10.73% | Upgrade
|
| D&A For EBITDA | 7.56 | 54.45 | 58.62 | 51.88 | 27.13 | 17.22 | Upgrade
|
| EBIT | -36.76 | -207.1 | -410.24 | 93.94 | 174.2 | 606.48 | Upgrade
|
| EBIT Margin | -17.59% | -8.30% | -9.90% | 1.50% | 2.71% | 10.43% | Upgrade
|
| Effective Tax Rate | - | - | - | 7.28% | 11.94% | 11.96% | Upgrade
|
| Advertising Expenses | - | - | - | - | - | 72.27 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.